Evidence map›Paper›PMID 28954234›Full record

ArticleCell reports2017

Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling.

Christophe J Queval, Ok-Ryul Song, Jean-Philippe Carralot, Jean-Michel Saliou, Antonino Bongiovanni, Gaspard Deloison, Nathalie Deboosère, Samuel Jouny, Raffaella Iantomasi, Vincent Delorme and 8 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Endogenous hepcidin plays an essential role inEmerging microbes & infections · 2025
    Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Host Immune Response toJournal of inflammation research · 2025
    Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 3 countries.

Christophe J QuevalUniversity Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France; Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, 75015 Paris, France.
Ok-Ryul SongUniversity Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France; Institut Pasteur Korea, 16 Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do 463-400, South Korea.
Jean-Philippe CarralotInstitut Pasteur Korea, 16 Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do 463-400, South Korea.
Jean-Michel SaliouUniversity Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France; Plateforme de Protéomique et Peptides Modifiés (P3M), CNRS, Institut Pasteur de Lille, University Lille, 59000 Lille, France.
Antonino BongiovanniUniversity Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France.
Gaspard DeloisonUniversity Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France.
Nathalie DeboosèreUniversity Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France.
Samuel JounyUniversity Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France.
Raffaella IantomasiUniversity Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France.
Vincent DelormeUniversity Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France; Institut Pasteur Korea, 16 Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do 463-400, South Korea.
Anne-Sophie DebrieUniversity Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France.
Sei-Jin ParkInstitut Pasteur Korea, 16 Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do 463-400, South Korea.
Joana Costa GouveiaUniversity Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France.
Stanislas TomavoUniversity Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France; Plateforme de Protéomique et Peptides Modifiés (P3M), CNRS, Institut Pasteur de Lille, University Lille, 59000 Lille, France.
Roland BroschInstitut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, 75015 Paris, France.
Akihiko YoshimuraDepartment of Microbiology and Immunology, Keio University School of Medicine, 35 Shinanomachi, Shinjyuku-ku, Tokyo 160-8582, Japan.
Edouard YeramianUnité de Microbiologie Structurale, CNRS UMR3528 Institut Pasteur, 75015 Paris, France. Electronic address: edouard.yeramian@pasteur.fr.
Priscille BrodinUniversity Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France; Institut Pasteur Korea, 16 Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do 463-400, South Korea. Electronic address: priscille.brodin@inserm.fr.
Centre National de la Recherche Scientifique · FRInstitut Pasteur de Lille · FRCentre Hospitalier Universitaire de Lille · FRInstitut Pasteur Korea · KRCenter for Infection and Immunity of Lille · FRInserm · FRInstitut Pasteur · FRKeio University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathogens have evolved a range of mechanisms to counteract host defenses, notably to survive harsh acidic conditions in phagosomes. In the case of Mycobacterium tuberculosis, it has been shown that regulation of phagosome acidification could be achieved by interfering with the retention of the V-ATPase complexes at the vacuole. Here, we present evidence that M. tuberculosis resorts to yet another strategy to control phagosomal acidification, interfering with host suppressor of cytokine signaling (SOCS) protein functions. More precisely, we show that infection of macrophages with M. tuberculosis leads to granulocyte-macrophage colony-stimulating factor (GM-CSF) secretion, inducing STAT5-mediated expression of cytokine-inducible SH2-containing protein (CISH), which selectively targets the V-ATPase catalytic subunit A for ubiquitination and degradation by the proteasome. Consistently, we show that inhibition of CISH expression leads to reduced replication of M. tuberculosis in macrophages. Our findings further broaden the molecular understanding of mechanisms deployed by bacteria to survive.

Indexed as

AnimalsMiceMycobacterium tuberculosisPhagosomesSignal TransductionSuppressor of Cytokine Signaling ProteinsSuppressor of Cytokine Signaling ProteinsCISHGM-CSFhigh-content imagingH(+) V-ATPasemacrophagesMycobacterium tuberculosisphagosome acidificationprotosomal degradationSTAT5ubiquitination

Identifiers

PMID28954234
PMCPMC5637157
OpenAlexW2756935311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.